- Patent Title: Heterodimeric vascular endothelial growth factor and use thereof
-
Application No.: US15780734Application Date: 2016-12-02
-
Publication No.: US10851142B2Publication Date: 2020-12-01
- Inventor: Alan Yueh-Luen Lee , Jui-Ling Tsai
- Applicant: National Health Research Institutes
- Applicant Address: TW Zhunan
- Assignee: National Health Research Institutes
- Current Assignee: National Health Research Institutes
- Current Assignee Address: TW Zhunan
- Agency: Cesari and McKenna, LLP
- International Application: PCT/US2016/064554 WO 20161202
- International Announcement: WO2017/096124 WO 20170608
- Main IPC: A61K38/18
- IPC: A61K38/18 ; C07K14/475
Abstract:
A fusion protein, comprising: (i) a first vascular endothelial growth factor (VEGF) isoform, and (ii) a second VEGF isoform, and (iii) a dimerization domain between the first isoform and the second isoform, wherein the first isoform and the second isoform are selected from VEGF121 and VEGF165.
Public/Granted literature
- US20180355004A1 HETERODIMERIC VASCULAR ENDOTHELIAL GROWTH FACTOR AND USE THEREOF Public/Granted day:2018-12-13
Information query
IPC分类:
